लोड हो रहा है...

Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma

Aim. A total of 329 patients with hepatocellular carcinoma have been treated at our unit since 1990. Following the randomized controlled trial in Hong Kong by Lau et al. in 1999, patients have been offered adjuvant lipiodol I-131. The aim of this study was to determine the effectiveness of adjuvant...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Ng, K. M., Niu, R., Yan, T. D., Zhao, J., McKay, E., Chu, F. C. K., Morris, D. L.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2008
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2597328/
https://ncbi.nlm.nih.gov/pubmed/19088923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13651820802074449
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!